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Previewscellular targeting? If so, how might this
impact their therapeutic potential? It has
already been demonstrated that anti-
bodies directed against PS can neutralize
lethal pichinde and cytomegalo virus
infections in animals (Soares et al.,
2008). For the poxviruses and other
human pathogens using apoptotic
mimicry (HIV, Ebola, etc.), can PS expo-
sure be used as a potential antiviral
target? Future efforts should be directed
at exploiting pathogen PS exposure to
this end.
The significance of viral proteins in the
activation of host cell signaling and virus
entry is well understood. The work by
Morizono and colleagues will undoubt-
edly lead to future experimentation
directed at understanding the role of viruslipids during these processes. Addition-
ally, this study will likely stimulate further
investigation of viral apoptotic mimicry
mechanisms used by these and other
viruses.ACKNOWLEDGMENTS
I apologize to those individuals whose work was
not cited due to space limitations. J.M. is sup-
ported by a Swiss National Science Foundation
Ambizione Award (PZ00P3_131988).REFERENCES
Callahan, M.K., Popernack, P.M., Tsutsui, S.,
Truong, L., Schlegel, R.A., and Henderson, A.J.
(2003). J. Immunol. 170, 4840–4845.
Ishimoto, Y., Ohashi, K., Mizuno, K., and Nakano,
T. (2000). J. Biochem. 127, 411–417.Cell Host & MicrobLemke, G., and Burstyn-Cohen, T. (2010). Ann. N.
Y. Acad. Sci. 1209, 23–29.
Mercer, J., and Helenius, A. (2008). Science 320,
531–535.
Morizono, K., Xie, Y., Olafsen, T., Lee, B.,
Dasgupta, A., Wu, A.M., and Chen, I.S.Y. (2011).
Cell Host Microbe 9, this issue, 286–298.
Shimojima, M., Takada, A., Ebihara, H., Neumann,
G., Fujioka, K., Irimura, T., Jones, S., Feldmann, H.,
and Kawaoka, Y. (2006). J. Virol. 80, 10109–10116.
Soares, M.M., King, S.W., and Thorpe, P.E. (2008).
Nat. Med. 14, 1357–1362.
Vanlandschoot, P., and Leroux-Roels, G. (2003).
Trends Immunol. 24, 144–147.
Wanderley, J.L., and Barcinski, M.A. (2010). Cell.
Mol. Life Sci. 67, 1653–1659.
Zhou, Z., and Yu, X. (2008). Trends Cell Biol. 18,
474–485.Leishmania Parasites Act as a Trojan Horse
that Paralyzes the Translation System
of Host MacrophagesMichal Shapira1,* and Alexandra Zinoviev1
1Department of Life Sciences, Ben Gurion University of the Negev, POB 653, Beer Sheva 84105, Israel
*Correspondence: shapiram@bgu.ac.il
DOI 10.1016/j.chom.2011.04.004
GP63 is an abundant GPI-anchored surface metalloprotease of Leishmania. Jaramillo et al. (2011) show that
GP63 manipulates the translation system of host macrophages by cleaving mTOR, which leads to 4E-BP1
dephosphorylation. This study pioneers the observation that Leishmania parasites metabolically paralyze
their host cells using an elegant translation shutoff mechanism.Leishmania parasites are the causative
agents of a broad spectrum of diseases
that affect millions of people across the
Old and New Worlds and inflict morbidity
and mortality when untreated. The para-
sites lead a complex life cycle, in which
the flagellated promastigote form resides
in the alimentary canal of female sand
flies. During the blood meal, the parasites
are transmitted into the circulation system
of a mammal, where they are phagocy-
tized by macrophages and subsequently
transform into the nonmotile amastigote
form. The obligatory intracellular amasti-
gotes reside within phagolysosomal
vacuoles and adopt sophisticated mech-anisms that enable them to avoid the
hostile defense system of their host
organism. The interplay between the
parasite and its host is a complex pro-
cess, in which the paramount interest of
the parasite is to restrict the immune and
microbicidal activities of themacrophage,
while keeping it alive as a nutritional
source.
Leishmania parasites encode a highly
abundant surface protein, GP63 (Bordier,
1987), which is associated with parasite
virulence (McGwire et al., 2003). Due to
its high abundance and its key role in the
progression of the disease, GP63 has
been a major target for efforts to developa vaccine against Leishmania. GP63 is
anchored to the cell membrane by a
GPI-anchor and functions as a secreted
zinc metalloprotease. It was recently re-
ported to promote the cleavage-depen-
dent activation of macrophage protein
tyrosinephosphatases, aspart of a refined
mechanism that downregulates host cell
functions and inhibits host defense
systems (Contreras et al., 2010; Gomez
et al., 2009).
In this issue, Jaramillo et al. unveil an
interesting new role for the parasite viru-
lence factor GP63 on the translation
machinery of the infected macrophage
(Jaramillo et al., 2011). The authors showe 9, April 21, 2011 ª2011 Elsevier Inc. 257
Figure 1. Model for the ‘‘Remote Control’’ of Protein Synthesis in
Leishmania-Infected Macrophages
Leishmania parasites are phagocytosed by macrophages, where they reside
within phagolysosomal vacuoles. The parasite surface is covered by an abun-
dant GPI-anchored metalloprotease, GP63 (green pentagons), which can be
secreted into the parasite environment. GP63 expression is required to cleave
mTOR (red and blue rectangle) and hence dephosphorylate 4E-BP1 (yellow
circle; phosphate groups are represented by red stars). 4E-BP1 is a transla-
tional repressor that is activated upon dephosphorylation. Once dephosphory-
lated, 4E-BP1 binds the cap-binding protein eIF4E (blue crescent). This
prevents the formation of the translation pre-initiation complex and causes
global inhibition of cap-dependent translation initiation in the macrophage.
GP63 expression is also required to reduce IFN a/b production, although
a direct effect has not been shown, as indicated by the dashed lines. Type I
IFN plays an important role in the macrophage defense system, and therefore
the GP63-mediated reduction in type I IFN production lowers resistance to
infection.
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Previewsthat infection by Leishmania
parasites leads to a global
repression of protein syn-
thesis in host macrophages.
This is achieved by activation
of 4E-BP1, a translational
repressor that inhibits cap-
dependent translation initia-
tion. 4E-BP1 binds eIF4E, the
cap-binding translation initia-
tion factor, thus preventing
its interaction with the scaf-
fold protein of the preinitiation
complex, eIF4G. Inhibition of
the eIF4E-eIF4G interaction
efficiently represses cap-
dependent translation initia-
tion. 4E-BP1 activity is
subject to tight control by
a signaling pathway that regu-
lates its phosphorylation
status; binding of eIF4E is
possible only if 4E-BP1 is
nonphosphorylated. Phos-
phorylation of 4E-BP1 by
mTOR prevents its interaction
with eIF4E, relieving the re-
pression of translation (Ging-
ras et al., 1999). The authors
show that GP63 cleaves
macrophage mTOR, which
subsequently prevents the
formation of mTORC1. As a
result, macrophage 4E-BP1
is nonphosphorylated, main-taining an inactive eIF4E. This observation
is supported by the positive effect of
rapamycin, an inhibitor of mTOR, on the
proliferation of Leishmania inside the
macrophage. Cleavage of mTOR and
activation of 4E-BP1 occur in parallel to
inhibition of type I IFN expression, an
important component that is used to
combat the parasites (Figure 1). The direct
manner by which IFN production is
decreased remains elusive, although it
can easily be related to the general inhibi-
tion of translation.
The interesting conclusion that GP63
controls translation of the host cell is sup-
ported by a genetic approach employed
for both the parasite and its host. On
one hand, macrophages lacking the
eif4ebp1 and eif4ebp2 genes show higher
resistance to Leishmania infection and
a decrease in the parasite load. On the
other hand, infection with the GP63
knockout mutant of Leishmania fails to
downregulate global translation of the258 Cell Host & Microbe 9, April 21, 2011 ª2infectedmacrophages, whereas restoring
GP63 expression rescues this effect.
Finally, the authors show that induc-
tion of IFN a and b, important compo-
nents of the antileishmanial response in
the host, is also associated with the
altered translation activity of the host
cells. Protection against the spread of
Leishmania parasites is achieved by
increased levels of type I IFN (Diefenbach
et al., 1998), an inducer of nitric oxide
synthase, iNOS. The therapeutic and pro-
tective effects of type I IFN against
Leishmania infection have been shown
both experimentally and clinically. The
authors demonstrate that expression of
host type I IFN increases in 4E-BP1/2
double-knockout mice and macro-
phages, where progression of Leishmania
infection is inhibited. The authors con-
clude that the parasite-resistant pheno-
type correlates well with increased type I
IFN levels and elevated iNOS activity
both in vitro and in vivo.011 Elsevier Inc.The hijacking of cellular
pathways by foreign intruders
is well documented in viral
infections. Poliovirus for
example, is known to dephos-
phorylate 4E-BP1 (Gingras
et al., 1996) and to cleave
eIF4G (Gradi et al., 1998).
Through these mechanisms,
viruses prevent the assembly
of preinitiation complexes
on the 50 cap structures. This
causes a global arrest of
host cell protein synthesis,
whereas viral mRNAs bypass
this inhibition using IRES ele-
ments (Belsham and Sonen-
berg, 2000). Other viruses
also affect the host transcrip-
tion system, allowing them
to exploit the host cell for
their own proliferation. Unlike
viruses, intracellular parasites
do not use the hostmachinery
for replication, transcription,
RNA processing, or transla-
tion of their genes, since they
rely on their own independent
systems. It is therefore sur-
prising that intracellular para-
sites control specific path-
ways in their host cells to
enhance their own survival.
This is the first report on a
protozoan parasite that mani-pulates the host translation machinery to
its advantage. GP63 has been implicated
as an important component in this mode
of action. It is secreted by the parasites
and can affect the host cells even in its
soluble secreted form. GP63 targets
components of multiple pathways in the
host cell, including the translation and
transcription systems. It was recently
reported that GP63 also cleaves macro-
phage c-Jun, which is part of the AP-1
complex, thus halting various cellular
processes (Contreras et al., 2010). It is
important to note that despite these
dramatic effects on their host cells,
Leishmania parasites do not kill the tar-
geted macrophage immediately upon
entry. The outcome is that during parasite
invasion, the macrophages declare
war against these intruders, and, in turn,
the parasites devise clever processes
that downregulate the host’s protective
actions. This battle is managed by a
‘‘remote control’’ mechanism that is
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Previewsmediated by GP63 of Leishmania. It
affects different metabolic pathways of
the host cell mainly by cleaving important
signaling molecules and transcription
factors of the host, to finally downregulate
the antiparasitic response.REFERENCES
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